<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">GLIMEPIRIDE</span><br/>(gli-me'pi-ride)<br/><span class="topboxtradename">Amaryl<br/></span><b>Classifications:</b> <span class="classification">hormones and synthetic substitutes</span>; <span class="classification">antidiabetic</span>; <span class="classification">sulfonylurea</span><br/><b>Prototype: </b>Glyburide<br/><b>Pregnancy Category: </b>C<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>1 mg, 2 mg, 4 mg tablets</p>
<h1><a name="action">Actions</a></h1>
<p>Second-generation sulfonylurea hypoglycemic agent used for once-a-day dosing.</p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Directly stimulates functioning pancreatic beta cells to secrete insulin, leading to direct drop in blood glucose. Indirect
         action leads to increased sensitivity of peripheral insulin receptors, resulting in increased insulin binding in peripheral
         tissues. Glimepiride improves postprandial glycemic control.
      </p>
<h1><a name="uses">Uses</a></h1>
<p>Adjunct to diet and exercise in patients with type 2 diabetes, may also be used in combination with insulin in type 2 diabetes.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to glimepiride, diabetic ketoacidosis, pregnancy (category C), lactation, nondiabetic patients with renal
         glycosuria.
      </p>
<h1><a name="precaution">Cautious Use</a></h1>
<p>Previous hypersensitivity to other sulfonylureas, sulfonamides, or thiazide diuretics; hypoglycemia or conditions predisposing
         to hypoglycemia (e.g., prolonged nausea and vomiting, alcohol ingestion, renal or hepatic function impairment, severe infections,
         surgery). Safe use in children is not established.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Type 2 Diabetes Mellitus</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> Start with 12 mg once daily with breakfast or first main meal, may increase to usual maintenance dose of 14 mg
               once daily (max: 8 mg/d)<br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give with breakfast or first main meal.</li>
<li>
            				Note: Maximum starting dose is <img src="../images/special/lesserorequal.gif"/>2 mg. With renal or hepatic insufficiency, initial
            recommended dose is 1 mg. Increase by <img src="../images/special/lesserorequal.gif"/>2 mg at 1- to 2-wk intervals maximum
            of 8 mg/d.
            			
         </li>
<li>Store in tightly closed container at 15°30° C (59°86° F).</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">CNS:</span> Dizziness, asthenia, headache, blurred vision, changes in accommodation. <span class="typehead">GI:</span> Nausea, vomiting, diarrhea, abdominal pain. <span class="typehead">Hematologic:</span> Leukopenia, <span class="speceff-life">agranulocytosis</span> (rare), thrombocytopenia. <span class="typehead">Metabolic:</span> Hypoglycemia. <span class="typehead">Skin:</span> Rash, pruritus, erythema, urticaria, maculopapular eruptions. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span> Hypoglycemic effects may be potentiated by other highly protein-bound drugs (e.g., <span class="classification">adrenergic antagonists</span>, <b>chloramphenicol,</b>
<span class="classification">mao inhibitors</span>, <span class="classification">nsaids</span>, <b>probenecid,</b>
<span class="classification">salicylates, sulfonamides,</span>
<b>warfarin</b>). <span class="classification">corticosteroids</span>, <b>phenytoin,</b>
<b>isoniazid,</b>
<b>nicotinic acid,</b>
<span class="classification">sympathomimetic amines</span>, <span class="classification">thiazide diuretics</span> may attenuate effects of glimepiride. <span class="typehead">Herbal:</span>
<b>Ginseng,</b>
<b>garlic</b> may increase hypoglycemic effects. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Completely absorbed from GI tract. <span class="typehead">Onset:</span> 1 h. <span class="typehead">Peak:</span> 23 h. <span class="typehead">Distribution:</span> &gt;99.5% protein bound; probably secreted into breast milk. <span class="typehead">Metabolism:</span> Metabolized in liver by cytochrome P4502C9 (CYP2C9). <span class="typehead">Elimination:</span> 60% excreted in urine, 40% in feces. <span class="typehead">Half-Life:</span> 59 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Lab tests: monitor fasting and postprandial blood glucose and urinary glucose frequently. Monitor glycosylated hemoglobin
            every 36 mo. Monitor periodically during long-term therapy: Liver function tests, serum osmolarity, serum sodium, and
            CBC with differential.
         </li>
<li>Monitor for hypoglycemia especially with concurrent drugs which enhance hypoglycemic effects.</li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Take a missed dose as soon as possible unless it is almost time for next dose; <small>NEVER</small> take two doses at the same time.
         </li>
<li>Avoid drinking alcohol or using OTC drugs without informing physician.</li>
<li>Use sunscreen and avoid sunlamps.</li>
<li>Learn about adverse reactions and drug interactions.</li>
<li>Do not breast feed while taking this drug.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>